Who Paid My Doc
ABP 654 P3 PsO Study
Research payments
$6,067,158
Through program year 2024, $6,067,158 in research payments was reported against ABP 654 P3 PsO Study, across 174 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $6,000 | 1 |
| 2022 | Research | $415,456 | 30 |
| 2021 | Research | $5,645,702 | 143 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Mark Amster Brighton, MA Named on 6 payments
- Suzanne Bruce Houston, TX Named on 6 payments
- Rosalyn George Wilmington, NC Named on 6 payments
- Zoe Draelos High Point, NC Named on 5 payments
- David Greenstein Beverly, MA Named on 5 payments
- Andrew Blauvelt Portland, OR Named on 5 payments
- Jerry Bagel East Windsor, NJ Named on 5 payments
- Stephanie Mehlis Skokie, IL Named on 5 payments
- Phoebe Rich Portland, OR Named on 5 payments
- Mark McCune Overland Park, KS Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.